Jian Wenying, Lee Seon Hwa, Williams Michelle V, Blair Ian A
From the Centers for Cancer Pharmacology and Excellence in Environmental Toxicology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6160.
J Biol Chem. 2009 Jun 19;284(25):16799-16807. doi: 10.1074/jbc.M109.011841. Epub 2009 Apr 23.
Lipoxygenases (LOs) convert polyunsaturated fatty acids into lipid hydroperoxides. Homolytic decomposition of lipid hydroperoxides gives rise to endogenous genotoxins such as 4-oxo-2(E)-nonenal, which cause the formation of mutagenic DNA adducts. Chiral lipidomics analysis was employed to show that a 5-LO-derived lipid hydroperoxide was responsible for endogenous DNA-adduct formation. The study employed human lymphoblastoid CESS cells, which expressed both 5-LO and the required 5-LO-activating protein (FLAP). The major lipid peroxidation product was 5(S)-hydroperoxy-6,8,11,14-(E,Z,Z,Z)-eicosatetraenoic acid, which was analyzed as its reduction product, 5(S)-hydroxy-6,8,11,14-(E,Z,Z,Z)-eicosatetraenoic acid (5(S)-HETE)). Concentrations of 5(S)-HETE increased from 0.07 +/- 0.01 to 45.50 +/- 4.05 pmol/10(7) cells upon stimulation of the CESS cells with calcium ionophore A23187. There was a concomitant increase in the 4-oxo-2(E)-nonenal-derived DNA-adduct, heptanone-etheno-2'-deoxyguanosine (HepsilondGuo) from 2.41 +/- 0.35 to 6.31 +/- 0.73 adducts/10(7) normal bases. Biosynthesis of prostaglandins, 11(R)-hydroxy-5,8,12,14-(Z,Z,E,Z)-eicosatetraenoic acid, and 15(R,S)-hydroxy-5,8,11,13-(Z,Z,Z,E)-eicosatetraenoic acid revealed that there was cyclooxygenase (COX) activity in the CESS cells. Western blot analysis revealed that COX-1 was expressed by the cells, but there was no COX-2 or 15-LO-1. FLAP inhibitor reduced HepsilondGuo-adducts and 5(S)-HETE to basal levels. In contrast, aspirin, which had no effect on 5(S)-HETE, blocked the formation of prostaglandins, 15-HETE, and 11-HETE but did not inhibit HepsilondGuo-adduct formation. These data showed that 5-LO was the enzyme responsible for the generation of the HepsilondGuo DNA-adduct in CESS cells.
脂氧合酶(LOs)将多不饱和脂肪酸转化为脂质氢过氧化物。脂质氢过氧化物的均裂分解会产生内源性基因毒素,如4-氧代-2(E)-壬烯醛,其会导致诱变DNA加合物的形成。采用手性脂质组学分析表明,一种5-LO衍生的脂质氢过氧化物是内源性DNA加合物形成的原因。该研究使用了人类淋巴母细胞样CESS细胞,其同时表达5-LO和所需的5-LO激活蛋白(FLAP)。主要的脂质过氧化产物是5(S)-氢过氧-6,8,11,14-(E,Z,Z,Z)-二十碳四烯酸,将其作为还原产物5(S)-羟基-6,8,11,14-(E,Z,Z,Z)-二十碳四烯酸(5(S)-HETE)进行分析。在用钙离子载体A23187刺激CESS细胞后,5(S)-HETE的浓度从0.07±0.01增加到45.50±4.05 pmol/10⁷个细胞。4-氧代-2(E)-壬烯醛衍生的DNA加合物庚酮-乙烯基-2'-脱氧鸟苷(HepsilondGuo)也随之从2.41±0.35增加到6.31±0.73个加合物/10⁷个正常碱基。前列腺素、11(R)-羟基-5,8,12,14-(Z,Z,E,Z)-二十碳四烯酸和15(R,S)-羟基-5,8,11,13-(Z,Z,Z,E)-二十碳四烯酸的生物合成表明,CESS细胞中存在环氧化酶(COX)活性。蛋白质免疫印迹分析显示,细胞表达COX-1,但不表达COX-2或15-LO-1。FLAP抑制剂将HepsilondGuo加合物和5(S)-HETE降低至基础水平。相比之下,对5(S)-HETE无影响的阿司匹林可阻断前列腺素、15-HETE和11-HETE的形成,但不抑制HepsilondGuo加合物的形成。这些数据表明,5-LO是CESS细胞中产生HepsilondGuo DNA加合物的酶。